MPs-ACT, an Assay to Evaluate the Procoagulant Activity of Microparticles
Clinical and Applied Thrombosis/Hemostasis · 2023
DOI: 10.1177/10760296231159374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, 2023. Verfasst von Yalong Gao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Post-Neurotrauma Neurorepair and Regeneration in Central Nervous System, Ministry of Education and Tianjin Neurological Institute, …. Hauptthemen laut MEDLINE: Thrombophilia, Cell-Derived Microparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The procoagulant effect of microparticles (MPs) contributes to hypercoagulability-induced thrombosis. We provide preliminary findings of the MPs-Activated Clotting Time (MPs-ACT) assay to determine the procoagulant activity of MPs. MPs-rich plasma was obtained and recalcified. Changes in plasma viscoelasticity were evaluated and the time to the peak viscoelastic changes was defined as the MPs-ACT. MPs concentration was measured by flow cytometry. Coagulation products produced during plasma clotting were identified by fibrin and fibrinopeptide A. MPs were prepared in vitro and added to standard plasma to simulate pathological samples. In addition, reproducibility and sensitivity were evaluated. We confirmed the linear relationship between MPs-ACT and MP concentrations. Dynamic changes in fibrin production were depicted. We simulated the correlation between MPs-ACT and standard plasma containing MPs prepared in vitro. The reproducibility of high-value and low-value samples was 6.0% and 10.8%, respectively. MPs-ACT sensitively detected hypercoagulable samples from patients with pre-eclampsia, hip fractures, and lung tumors. MPs-ACT largely reflects the procoagulant effect of MPs. MPs-ACT sensitively and rapidly detects hypercoagulability with MPs-rich plasma. It may be promising for the diagnosis of hypercoagulable states induced by MPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Post-Neurotrauma Neurorepair and Regeneration in Central Nervous System, Ministry of Education and Tianjin Neurological Institute, 117865Tianjin Medical University General Hospital, Tianjin, China.
- Department of General Surgery, 117865Tianjin Medical University General Hospital, Tianjin, China.
- Precision Medicine Center, 117865Tianjin Medical University General Hospital, Tianjin, China.
ORCID-Profile: Li Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Gao, Y., Li, X., Qin, Y., Men, J., Ren, J., Li, X., Xu, C., Li, Q., Li, Y., Cui, W., Zhang, S., Li, L., Li, Y., Zhang, J., & Liu, L. (2023). MPs-ACT, an Assay to Evaluate the Procoagulant Activity of Microparticles. Clinical and Applied Thrombosis/Hemostasis. https://doi.org/10.1177/10760296231159374
Vancouver
Gao Y, Li X, Qin Y, Men J, Ren J, Li X, et al. MPs-ACT, an Assay to Evaluate the Procoagulant Activity of Microparticles. Clinical and Applied Thrombosis/Hemostasis. 2023. doi:10.1177/10760296231159374
BibTeX
@article{Gao2023,
author = {Gao, Yalong and Li, Xiaotian and Qin, Yafei and Men, Jianlong and Ren, Jing and Li, Xiaochun and Xu, Chunlei and Li, Qifeng and Li, Ying and Cui, Weiyun and Zhang, Shu and Li, Lei and Li, Yaohua and Zhang, Jianning and Liu, Li},
title = {MPs-ACT, an Assay to Evaluate the Procoagulant Activity of Microparticles},
journal = {Clinical and Applied Thrombosis/Hemostasis},
year = {2023},
doi = {10.1177/10760296231159374}
}
EUVIMED